Can-Fite BioPharma Ltd. Sponsored ADR
(NYSE Amex Equities : CANF)

( )
CANF PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.61%93.101.3%$988.29m
BIIBBiogen Inc.
-2.52%224.401.3%$650.41m
AMGNAmgen Inc.
-0.81%178.301.3%$468.17m
GILDGilead Sciences, Inc.
-0.38%62.800.9%$434.85m
ILMNIllumina, Inc.
-2.34%314.523.5%$280.91m
REGNRegeneron Pharmaceuticals, Inc.
-1.07%340.462.6%$279.54m
VRTXVertex Pharmaceuticals Incorporated
-1.59%172.581.9%$238.29m
ALXNAlexion Pharmaceuticals, Inc.
-1.72%130.092.0%$169.34m
EXASExact Sciences Corporation
1.27%95.1325.3%$167.52m
AAgilent Technologies, Inc.
0.30%75.791.6%$145.62m
SRPTSarepta Therapeutics, Inc.
0.06%118.1614.7%$133.09m
ONCESpark Therapeutics, Inc.
0.06%110.6711.2%$117.72m
INCYIncyte Corporation
-2.51%73.522.5%$96.42m
IONSIonis Pharmaceuticals, Inc.
-2.23%73.338.3%$95.85m
BMRNBioMarin Pharmaceutical Inc.
-0.59%85.494.3%$92.14m

Company Profile

Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. Its products include pipeline drugs such as CF101, CF102 and CF602. The company offers drugs for the treatment of Psoriasis, Rheumatic Arthritis, Glaucoma, Uveitis, Crohn's disease, Osteoathritis, Hepatitis C, and Liver Cancer. Can-Fite BioPharma was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach Tikva, Israel.